Josh Cain, PhDCognitive Neuroscientist

Cognitive Neuroscientist with uniquely broad, cross-sector leadership experience spanning basic research, clinical trials, computational/statistical methods, and the neurotech industry. Led 10+ professional research programs from inception through completion, including works published in Nature, Brain Stimulation, and PLOS ONE, with a track record of translating complex, cutting-edge science into high-impact, cross-functional, and successful programs at scale. Pioneered Transcranial Focused Ultrasound (tFUS; also: LIFU, LIFUP) for human neuromodulation — including (1) leading the world's first clinical trial using FUS to induce recovery from coma, (2) leading landmark human studies, (3) publishing field-enabling software, as well as (4) establishing tFUS labs and training the scientists comprising much of this now rapidly growing field. Held C-suite roles at multiple early-stage neurotechnology companies, pairing deep scientific rigor with translational leadership across research, clinical, and operational environments. Operates with full independence across the complete program lifecycle — from strategic planning and stakeholder negotiation through execution, regulatory navigation, and public dissemination. Featured in The LA Times, Voice of America, Scientific American, and 40+ international publications for pioneering work in neuromodulation and clinical neuroscience.